Annotations: 9H40

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B [auth C]	PF01565	FAD binding domain (FAD_binding_4)	FAD binding domain	This family consists of various enzymes that use FAD as a co-factor, most of the enzymes are similar to oxygen oxidoreductase. One of the enzymes Vanillyl-alcohol oxidase (VAO) has a solved structure, the alignment includes the FAD binding site, call ...	This family consists of various enzymes that use FAD as a co-factor, most of the enzymes are similar to oxygen oxidoreductase. One of the enzymes Vanillyl-alcohol oxidase (VAO) has a solved structure, the alignment includes the FAD binding site, called the PP-loop, between residues 99-110 [1]. The FAD molecule is covalently bound in the known structure, however the residue that links to the FAD is not in the alignment. VAO catalyses the oxidation of a wide variety of substrates, ranging form aromatic amines to 4-alkylphenols. Other members of this family include D-lactate dehydrogenase, this enzyme catalyses the conversion of D-lactate to pyruvate using FAD as a co-factor; mitomycin radical oxidase, this enzyme oxidises the reduced form of mitomycins and is involved in mitomycin resistance. This family includes MurB an UDP-N-acetylenolpyruvoylglucosamine reductase enzyme EC:1.1.1.158. This enzyme is involved in the biosynthesis of peptidoglycan [2].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B [auth C]	p-cresol methylhydroxylase	D-lactate dehydrogenase (cytochrome) activity oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor oxidoreductase activity (2R)-oxo-acid reductase activity oxidoreductase activity, acting on CH-OH group of donors lactate dehydrogenase activity catalytic activity D-lactate dehydrogenase activity FAD binding flavin adenine dinucleotide binding binding nucleoside phosphate binding ion binding anion binding D-lactate dehydrogenase (cytochrome) activity oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor oxidoreductase activity (2R)-oxo-acid reductase activity oxidoreductase activity, acting on CH-OH group of donors lactate dehydrogenase activity catalytic activity D-lactate dehydrogenase activity FAD binding flavin adenine dinucleotide binding binding nucleoside phosphate binding ion binding anion binding nucleotide binding heterocyclic compound binding small molecule binding (2R)-2-hydroxyacid dehydrogenase (NAD+) activity oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor D-lactate dehydrogenase (NAD+) activity	catabolic process oxoacid metabolic process lactate catabolic process carboxylic acid metabolic process organic acid metabolic process organic acid catabolic process lactate metabolic process monocarboxylic acid catabolic process carboxylic acid catabolic process small molecule metabolic process metabolic process cellular process monocarboxylic acid metabolic process small molecule catabolic process	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B [auth C]	IPR016167	FAD-binding, type PCMH, subdomain 1	Homologous Superfamily
A, B [auth C]	IPR016164	FAD-linked oxidase-like, C-terminal	Homologous Superfamily
A, B [auth C]	IPR016170	Cytokinin dehydrogenase, C-terminal domain superfamily	Homologous Superfamily
A, B [auth C]	IPR036318	FAD-binding, type PCMH-like superfamily	Homologous Superfamily
A, B [auth C]	IPR016169	FAD-binding, type PCMH, subdomain 2	Homologous Superfamily
A, B [auth C]	IPR006094	FAD linked oxidase, N-terminal	Domain
A, B [auth C]	IPR016166	FAD-binding domain, PCMH-type	Domain
A, B [auth C]	IPR016171	Vanillyl-alcohol oxidase, C-terminal subdomain 2	Homologous Superfamily

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.